Sourcing high-purity bioregulatory peptides for laboratory investigations requires stringent analytical verification, structural confirmation, and batch consistency. PX1 Research operates as a premier domestic supplier of research-grade Chonluten, providing institutional and academic laboratories with fully documented, high-purity lots for in vitro and preclinical research applications.
Sourcing high-purity bioregulatory peptides for laboratory investigations requires stringent analytical verification, structural confirmation, and batch consistency. PX1 Research operates as a premier domestic supplier of research-grade Chonluten, providing institutional and academic laboratories with fully documented, high-purity lots for in vitro and preclinical research applications.
To buy bronchial mucosa renewal Chonluten from a qualified supplier, researchers must source from vendors that provide lot-specific certificates of analysis (COA), robust RP-HPLC mass spectrometry verification, and verified endotoxin testing. PX1 Research provides domestic, US-manufactured research-grade Chonluten synthesized under strict quality controls for qualified in vitro and preclinical laboratory investigations.
Navigating the vendor landscape for targeted bioregulatory peptides demands rigorous analytical standards. When acquiring compounds designed to target specialized cell types—such as bronchial epithelial cultures—investigators must ensure that the peptide sequence is exact, free of TFA counter-ion contamination, and maintained under sterile conditions. Sourcing directly from a dedicated vendor eliminates batch variability and guarantees accurate baseline data across repeated experimental runs.
PX1 Research maintains a fully domestic supply chain with rapid same-day shipping from California and Arizona facilities. Qualified laboratories evaluating the mechanisms of respiratory tissue repair can access full analytical documentation for every lot of Chonluten, ensuring complete alignment with institutional quality standards.
Chonluten is a synthetic short-chain bioregulatory peptide consisting of three amino acid residues: L-glutamic acid, L-aspartic acid, and glycine (H-Glu-Asp-Gly-OH, or EDG). Developed within the framework of short peptide regulatory signaling established by Khavinson and colleagues, Chonluten belongs to a specialized class of biological response modifiers engineered to penetrate cell membranes and interact directly with nuclear chromatin.
In nature, short peptide sequences act as endogenous signal transducers that modulate gene expression patterns during cellular stress, senescence, or tissue injury. The specific tripeptide motif of Chonluten was identified through tissue extract fractionation focusing on respiratory structures, specifically bronchial mucosa. By synthesized alignment of this tripeptide sequence, researchers can investigate isolated signaling events without the confounding factors present in crude tissue lysates.
As part of our comprehensive catalog of research peptides, PX1 Research supplies Chonluten as a lyophilized powder formulated strictly for laboratory investigation. Researchers investigating peptide structure-activity relationships can examine its biochemical physical constants, solubility parameters, and binding affinities across various in vitro models.
The bronchial mucosa serves as the primary barrier against inhaled environmental stressors, pathogens, and xenobiotics. Maintaining mucosal integrity requires coordinated cellular proliferation, differentiation of goblet and ciliated epithelial cells, and balanced cytokine secretion. Preclinical models investigating bronchial tissue dynamics utilize short peptides like Chonluten to observe how targeted regulatory signals influence cellular turnover and barrier restitution.
In vitro models utilizing primary human bronchial epithelial cells (HBECs) demonstrate that exposure to tripeptide bioregulators can modify protein expression profiles associated with structural integrity. Specifically, studies evaluating injury assays—such as mechanical scratch testing or chemical exposure models—indicate that Chonluten application correlates with enhanced cell migration and preservation of tight junction proteins like ZO-1 and occludin.
Furthermore, animal models of respiratory irritation indicate that administration of research-grade Chonluten reduces local markers of oxidative stress and downregulates pro-inflammatory signals within pulmonary parenchyma. These preclinical findings suggest that the compound acts as an epigenetic modulating agent that supports tissue homeostasis rather than a simple mitogen.
The underlying mechanism of short bioregulatory peptides relies on their ability to bind specific DNA motifs within gene promoter regions. Structural biology studies suggest that the Glu-Asp-Gly sequence fits into the major or minor grooves of double-stranded DNA, altering chromatin compaction and accessibility to RNA polymerase II.
In bronchial mucosa cell cultures, this epigenetic interaction has been shown to induce promoter site unmasking for genes regulating protein synthesis, ribosomal RNA transcription, and antioxidant defense enzymes. Preclinical transcriptomic analysis indicates that Chonluten exposure leads to selective up-regulation of genes responsible for surfactant protein expression and cell-cycle regulation in damaged respiratory tissues.
Unlike large polypeptide growth factors that act primarily via membrane-bound receptor tyrosine kinases, short peptides like Chonluten function through direct intracellular and nucleolar accumulation. To explore similar mechanisms across related organ systems, investigators often reference broader Khavinson peptide bioregulators within our research library.
Understanding how Chonluten compares to other short bioregulatory peptides enables researchers to select the precise tool for their tissue-specific assays. While Chonluten specifically targets bronchial mucosal pathways, other tripeptides and tetrapeptides exhibit specificity for different physiological tissue systems.
For instance, Vilon (Lys-Glu) is widely studied for its immunomodulatory effects and stimulation of splenocyte proliferation, whereas Cartalax (Ala-Glu-Asp) targets cartilage matrix synthesis and chondrocyte differentiation. When evaluating tissue repair models involving concurrent immune activation or systemic oxidative stress, researchers often compare Chonluten with Thymogen or pineal-derived bioregulators such as Epithalon.
The following matrix outlines key structural and functional distinctions among these short regulatory peptides in preclinical literature:
When purchasing peptides for sensitive cellular assays or transcriptomic studies, purity validation is critical. Minor peptide impurities, counter-ion residues (such as trifluoroacetic acid), or lipopolysaccharide (LPS) contamination can skew experimental results, alter cell viability, or cause false-positive inflammatory responses.
PX1 Research ensures that every batch of Chonluten undergoes comprehensive analytical validation. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) confirms chemical purity exceeding 98%, while Electrospray Ionization Mass Spectrometry (ESI-MS) verifies exact molecular weight and sequence identity.
Additionally, every lot undergoes chromogenic LAL testing to verify endotoxin levels below 0.01 EU/mg. This strict threshold ensures that observed cellular responses in mucosal tissue cultures are driven entirely by the peptide itself, rather than bacterial endotoxin contamination. Independent, third-party Certificates of Analysis (COA) are publicly available for every lot.
Chonluten is supplied as a sterile, lyophilized cake or powder. To preserve peptide stability and ensure accurate dosing in experimental setups, laboratories must follow standard biochemical handling procedures.
Reconstitution should be performed using sterile, bacteriostatic water or laboratory-grade phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of the downstream assay. Reconstituting under a laminar flow hood prevents microbial introduction. Gentle swirling is recommended; vortexing should be avoided to prevent shear stress on the peptide backbone.
For long-term preservation, lyophilized Chonluten should be stored at -20°C or -80°C protected from light. Once reconstituted, stock solutions should be divided into single-use aliquots to avoid repeated freeze-thaw cycles and stored at -20°C for short-term evaluation. Detailed protocol support for lab setup is available via our wholesale lab account portal.
PX1 Research operates with a non-negotiable commitment to analytical integrity, transparency, and domestic manufacturing standards. Unlike unverified overseas vendors, PX1 Research manufactures and packages peptides in US-based, ISO 17025-accredited and GMP-compliant facilities.
Every research compound shipped by PX1 Research comes backed by fully verifiable third-party analytical reports. We provide clear lot traceability, ensuring that institutional buyers receive identical purity and peptide content from order to order. Our logistics team dispatches orders same-day from facilities in California and Arizona to minimize transit delays and environmental exposure.
By prioritizing research-grade standards over consumer marketing, PX1 Research remains the preferred partner for academic departments, biotechnology firms, and contract research organizations (CROs) investigating bioregulatory peptide mechanisms.
What is the sequence and chemical formula of Chonluten?
Chonluten is a synthetic tripeptide with the chemical sequence L-Glu-L-Asp-Gly (H-Glu-Asp-Gly-OH). Its molecular formula is C11H17N3O8 with a molecular mass of approximately 319.27 g/mol.
Is Chonluten approved for human consumption or therapeutic use?
No. Chonluten supplied by PX1 Research is strictly for in vitro, cell culture, and preclinical laboratory research. It is not intended, labeled, or approved for human consumption, therapeutic use, or clinical application.
What analytical tests are provided with PX1 Research Chonluten?
Every lot of Chonluten is accompanied by an independent Certificate of Analysis featuring RP-HPLC (purity >98%), Mass Spectrometry (molecular weight confirmation), and LAL chromogenic endotoxin assay results.
How should Chonluten be reconstituted for in vitro cell assays?
Chonluten should be reconstituted in sterile laboratory-grade solvents such as PBS (pH 7.4) or sterile water under a laminar flow biosafety cabinet. Avoid high-shear vortexing to maintain molecular stability.
How does Chonluten differ from Vilon or Cartalax?
Chonluten (Glu-Asp-Gly) specifically targets bronchial epithelial and mucosal tissue signaling pathways. Vilon (Lys-Glu) targets immune cell/splenocyte pathways, while Cartalax (Ala-Glu-Asp) targets chondrocytes and connective tissue matrix synthesis.
What is the recommended storage temperature for lyophilized Chonluten?
Lyophilized Chonluten should be stored at -20°C or -80°C in a dry environment protected from light. Reconstituted aliquots should be frozen at -20°C and protected from multiple freeze-thaw cycles.
What are the endotoxin limits for PX1 Research compounds?
PX1 Research verifies that all research peptides meet strict endotoxin thresholds, maintaining levels below 0.01 EU/mg to prevent endotoxin-induced background artifact in cell assays.
How can academic institutions set up wholesale or bulk accounts for Chonluten?
Institutions and principal investigators can request bulk procurement, specialized custom vial sizing, and custom lot reservations through our dedicated wholesale portal at /wholesale.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.